Medtronic Price to Sales Ratio 2010-2024 | MDT
Historical PS ratio values for Medtronic (MDT) over the last 10 years. The current P/S ratio for Medtronic as of April 18, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Medtronic P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-04-18 | 79.19 | 3.27 | |
| 2024-01-31 | 86.82 | $24.25 | 3.58 |
| 2023-10-31 | 69.40 | $23.98 | 2.89 |
| 2023-07-31 | 85.58 | $23.68 | 3.61 |
| 2023-04-30 | 88.00 | $23.43 | 3.76 |
| 2023-01-31 | 80.27 | $23.00 | 3.49 |
| 2022-10-31 | 83.03 | $22.95 | 3.62 |
| 2022-07-31 | 87.25 | $23.05 | 3.79 |
| 2022-04-30 | 97.66 | $23.41 | 4.17 |
| 2022-01-31 | 96.28 | $23.47 | 4.10 |
| 2021-10-31 | 110.82 | $23.46 | 4.72 |
| 2021-07-31 | 120.83 | $23.33 | 5.18 |
| 2021-04-30 | 119.86 | $22.26 | 5.39 |
| 2021-01-31 | 101.42 | $20.65 | 4.91 |
| 2020-10-31 | 91.16 | $20.62 | 4.42 |
| 2020-07-31 | 86.95 | $20.67 | 4.21 |
| 2020-04-30 | 87.42 | $21.39 | 4.09 |
| 2020-01-31 | 102.76 | $22.96 | 4.48 |
| 2019-10-31 | 96.48 | $22.82 | 4.23 |
| 2019-07-31 | 89.86 | $22.62 | 3.97 |
| 2019-04-30 | 77.86 | $22.48 | 3.46 |
| 2019-01-31 | 77.07 | $22.44 | 3.44 |
| 2018-10-31 | 77.88 | $22.30 | 3.49 |
| 2018-07-31 | 77.84 | $21.96 | 3.54 |
| 2018-04-30 | 68.73 | $21.93 | 3.13 |
| 2018-01-31 | 73.67 | $21.67 | 3.40 |
| 2017-10-31 | 69.06 | $21.49 | 3.21 |
| 2017-07-31 | 71.60 | $21.60 | 3.31 |
| 2017-04-30 | 70.48 | $21.32 | 3.31 |
| 2017-01-31 | 64.14 | $20.94 | 3.06 |
| 2016-10-31 | 68.79 | $20.55 | 3.35 |
| 2016-07-31 | 73.14 | $20.21 | 3.62 |
| 2016-04-30 | 65.74 | $20.19 | 3.26 |
| 2016-01-31 | 62.74 | $21.47 | 2.92 |
| 2015-10-31 | 60.78 | $20.93 | 2.90 |
| 2015-07-31 | 64.11 | $20.38 | 3.15 |
| 2015-04-30 | 60.58 | $19.57 | 3.10 |
| 2015-01-31 | 57.87 | $17.49 | 3.31 |
| 2014-10-31 | 55.01 | $17.27 | 3.18 |
| 2014-07-31 | 49.59 | $17.03 | 2.91 |
| 2014-04-30 | 47.02 | $16.78 | 2.80 |
| 2014-01-31 | 45.01 | $16.62 | 2.71 |
| 2013-10-31 | 45.46 | $16.44 | 2.77 |
| 2013-07-31 | 43.52 | $16.27 | 2.68 |
| 2013-04-30 | 36.58 | $16.13 | 2.27 |
| 2013-01-31 | 36.31 | $15.85 | 2.29 |
| 2012-10-31 | 32.20 | $15.60 | 2.06 |
| 2012-07-31 | 30.35 | $15.40 | 1.97 |
| 2012-04-30 | 29.21 | $15.22 | 1.92 |
| 2012-01-31 | 29.32 | $14.84 | 1.97 |
| 2011-10-31 | 26.24 | $14.73 | 1.78 |
| 2011-07-31 | 27.03 | $14.54 | 1.86 |
| 2011-04-30 | 31.10 | $14.32 | 2.17 |
| 2011-01-31 | 28.38 | $14.04 | 2.02 |
| 2010-10-31 | 25.93 | $13.94 | 1.86 |
| 2010-07-31 | 27.03 | $13.79 | 1.96 |
| 2010-04-30 | 31.76 | $13.86 | 2.29 |
| 2010-01-31 | 31.03 | $13.86 | 2.24 |
| 2009-10-31 | 25.71 | $13.50 | 1.90 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $105.004B | $31.227B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.756B | 24.12 |
| Stryker (SYK) | United States | $127.849B | 31.70 |
| Boston Scientific (BSX) | United States | $99.704B | 33.15 |
| EssilorLuxottica (ESLOY) | France | $97.123B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.671B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.031B | 28.96 |
| ResMed (RMD) | United States | $25.568B | 25.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.922B | 16.05 |
| Terumo (TRUMY) | Japan | $24.880B | 35.14 |
| Baxter (BAX) | United States | $20.069B | 14.64 |
| Koninklijke Philips (PHG) | Netherlands | $18.712B | 14.93 |
| Insulet (PODD) | United States | $11.642B | 61.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.457B | 0.00 |
| Demant (WILYY) | Denmark | $10.001B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.295B | 24.71 |
| BellRing Brands (BRBR) | United States | $7.115B | 38.25 |
| Haemonetics (HAE) | United States | $4.311B | 22.05 |
| Lantheus Holdings (LNTH) | United States | $4.215B | 10.88 |
| Perrigo (PRGO) | Ireland | $4.071B | 11.64 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.378B | 15.97 |
| Envista Holdings (NVST) | United States | $3.367B | 12.80 |
| Green Thumb Industries (GTBIF) | United States | $2.758B | 87.40 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| QuidelOrtho (QDEL) | United States | $2.589B | 9.40 |
| ICU Medical (ICUI) | United States | $2.336B | 17.43 |
| TG Therapeutics (TGTX) | United States | $2.134B | 691.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.943B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| Owens & Minor (OMI) | United States | $1.836B | 17.62 |
| Agios Pharmaceuticals (AGIO) | United States | $1.631B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.486B | 46.29 |
| InMode (INMD) | Israel | $1.465B | 7.59 |
| LeMaitre Vascular (LMAT) | United States | $1.415B | 46.70 |
| AdaptHealth (AHCO) | United States | $1.253B | 9.43 |
| Warby Parker (WRBY) | United States | $1.189B | 0.00 |
| AtriCure (ATRC) | United States | $1.134B | 0.00 |
| MacroGenics (MGNX) | United States | $1.007B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.757B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.687B | 14.83 |
| BioLife Solutions (BLFS) | United States | $0.686B | 0.00 |
| Evolus (EOLS) | United States | $0.674B | 0.00 |
| Jin Medical (ZJYL) | China | $0.631B | 0.00 |
| Quanterix (QTRX) | United States | $0.602B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.591B | 0.00 |
| Valneva SE (VALN) | France | $0.538B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.533B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.521B | 11.29 |
| PetIQ (PETQ) | United States | $0.469B | 17.50 |
| ZimVie (ZIMV) | United States | $0.417B | 25.55 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
| Zynex (ZYXI) | United States | $0.388B | 44.70 |
| Surmodics (SRDX) | United States | $0.378B | 40.80 |
| Aurora Cannabis (ACB) | Canada | $0.316B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.303B | 30.08 |
| Cerus (CERS) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.256B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.243B | 14.80 |
| Ayr Wellness (AYRWF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.194B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.175B | 0.00 |
| Veru (VERU) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 21.93 |
| Eagleford Energy (GRUSF) | United States | $0.135B | 68.05 |
| InterCure (INCR) | Israel | $0.108B | 18.15 |
| Fonar (FONR) | United States | $0.105B | 8.98 |
| Allurion Technologies (ALUR) | United States | $0.104B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.104B | 0.00 |
| MariMed (MRMD) | United States | $0.101B | 0.00 |
| Safety Shot (SHOT) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.057B | 3.72 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.36 |
| ProSomnus (OSA) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |